» Articles » PMID: 37924819

Global Cancer Surgery: Pragmatic Solutions to Improve Cancer Surgery Outcomes Worldwide

Abstract

The first Lancet Oncology Commission on Global Cancer Surgery was published in 2015 and serves as a landmark paper in the field of cancer surgery. The Commission highlighted the burden of cancer and the importance of cancer surgery, while documenting the many inadequacies in the ability to deliver safe, timely, and affordable cancer surgical care. This Commission builds on the first Commission by focusing on solutions and actions to improve access to cancer surgery globally, developed by drawing upon the expertise from cancer surgery leaders across the world. We present solution frameworks in nine domains that can improve access to cancer surgery. These nine domains were refined to identify solutions specific to the six WHO regions. On the basis of these solutions, we developed eight actions to propel essential improvements in the global capacity for cancer surgery. Our initiatives are broad in scope, pragmatic, affordable, and contextually applicable, and aimed at cancer surgeons as well as leaders, administrators, elected officials, and health policy advocates. We envision that the solutions and actions contained within the Commission will address inequities and promote safe, timely, and affordable cancer surgery for every patient, regardless of their socioeconomic status or geographic location.

Citing Articles

Validation of an albumin-indocyanine green-based China liver cancer staging system to evaluating resectable hepatocellular carcinoma patients and comparison with the Child-Pugh-based China liver cancer staging system.

Chen M, Ren C, Wang M, Yu M, Wu B, Zhuang B Front Oncol. 2025; 15:1450333.

PMID: 40052123 PMC: 11882571. DOI: 10.3389/fonc.2025.1450333.


Geographic variations, temporal trends, and equity in healthcare resource allocation in China, 2010-21.

Yin S, Liu Z, Yu S, Li Y, An J, Wang D J Glob Health. 2025; 15():04008.

PMID: 39819771 PMC: 11737812. DOI: 10.7189/jogh.15.04008.


Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers.

Wu J, Lu J, Chen Q, Chen H, Zheng Y, Cheng M Front Pharmacol. 2024; 15:1494131.

PMID: 39555091 PMC: 11563798. DOI: 10.3389/fphar.2024.1494131.


Foundation models for fast, label-free detection of glioma infiltration.

Kondepudi A, Pekmezci M, Hou X, Scotford K, Jiang C, Rao A Nature. 2024; 637(8045):439-445.

PMID: 39537921 PMC: 11711092. DOI: 10.1038/s41586-024-08169-3.


Series on The Lancet Oncology Commission on Global Cancer Surgery-Action 1: Clinical Care and Access to Cancer Surgery.

Are C, Schissel M, Murthy S Ann Surg Oncol. 2024; 32(1):42-46.

PMID: 39511007 DOI: 10.1245/s10434-024-16167-y.